Organizational integration of acquired biotechnology companies in pharmaceutical companies: The need for a hybrid strategy

Schweizer, LarsLarsSchweizer2019-09-192014-09-2420050001-4273https://fis.uni-bamberg.de/handle/uniba/13029engOrganizational integration of acquired biotechnology companies in pharmaceutical companies: The need for a hybrid strategyarticle